Italy vs South Korea: Coverage of the human papillomavirus vaccine
Italy
68
in 2025
South Korea
67
in 2025
Italy rank
44th
South Korea rank
45th
Coverage of the human papillomavirus vaccine over time
- Italy
- South Korea
How they compare
Italy currently reports 68 against 67 in South Korea, a difference of 1.
The two have swapped places 4 times across 8 shared years of data; in 2018 it was Italy ahead.
Italy ranks 44th and South Korea ranks 45th of 85 countries.
Across the 2 decades both report, Italy averaged higher in 1 and South Korea in 1.
Head to head by decade
| Decade | Italy | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65 | 55.5 | 9.5 | Italy |
| 2020s | 66.5 | 69 | 2.5 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Italy or South Korea?
- Italy, at 68 against 67 in South Korea as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Italy and South Korea?
- 1, with Italy ahead.
- How many years of comparable data are there for Italy and South Korea?
- 8 years are reported by both, from 2018 to 2025.
- How do Italy and South Korea rank globally for coverage of the human papillomavirus vaccine?
- Italy ranks 44th and South Korea ranks 45th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.